Author: Rick Ng
Edition: 1
Publisher: Wiley-Liss
Binding: Hardcover
ISBN: 0471601500
Drugs-From Discovery to Approval
Statistics show that out of five thousand compounds with initial promise, five will go into human clinical trials, and only one will become an approved drug. Medical books Drugs-From Discovery to Approval. This tiny fraction illustrates the huge complexities involved in bringing a drug to market, a process that brings together scientific research, medical ethics, business, and various regulatory agencies.
Drugs-From Discovery to Approval presents a clear, step-by-step overview of the entire process. Using simple language, this comprehensive guide introduces basic concepts, then moves on to discuss disease target selection and the discovery processes for both small and large molecule drugs. Subsequent chapters explain preclinical studies, clinical trials, regulatory issues, good manufacturing practices (GMPs), and perspectives on the future Medical books Drugs from Discovery to Approval, 9780471601500. Drugs from Discovery to Approval, ISBN-13: 9780471601500, ISBN-10: 0471601500
Download link for Drugs-From Discovery to Approval
Drugs from Discovery to Approval, ISBN-13: 9780471601500, ISBN-10: 0471601500
Drugs: From Discovery to Approval
"Concise and easy to read, the book quickly introduces basic concepts, then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs." Doody's Reviews , May 2009 "The second edition of a book that offers a user-friendly step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of preclinical trials." Chemistry World , February 2009 The new edition of this best-selling book continues to offer a user-friendly, step-by-step introduction to all the key processes involved in bringing a
Drugs: From Discovery to Approval: Rick Ng
Medical Book Drugs-From Discovery to Approval
This tiny fraction illustrates the huge complexities involved in bringing a drug to market, a process that brings together scientific research, medical ethics, business, and various regulatory agencies.
Drugs-From Discovery to Approval presents a clear, step-by-step overview of the entire process. Using simple language, this comprehensive guide introduces basic concepts, then moves on to discuss disease target selection and the discovery processes for both small and large molecule drugs. Subsequent chapters explain preclinical studies, clinical trials, regulatory issues, good manufacturing practices (GMPs), and perspectives on the future. Coverage also includes:
* A helpful listing of current FDA and European guidelines
* A special section on regulatory authorities and processes in Japan and China
* Rich illustrations throughout, including more than ninety figures and tables
* Useful appendices on the history of drug discovery and development
* Representative examples of drug mechanisms in action
Written for professionals in the pharmaceutical industry, and readily accessible for students of pharmacy or medicine and others interested in drug discovery, Drugs-From Discovery to Approval represents a practical and approachable reference on this important process.
